NEW YORK (GenomeWeb News) – Genomics services provider ImaGenes has received certification from Roche NimbleGen to offer NimbleGen microarrays for chromatin immunoprecipitation (ChIP-chip) services, Roche NimbleGen said today.

Berlin-based ImaGenes passed a ChIP-chip certification using the NimbleGen Dual-Color workflow and the MS 200 Microarray Scanner to become a certified service provider. This certification enables ImaGenes to process samples for DNA-protein interactions and chromatin structure.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.